DE ROSSI, ANITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.232
AS - Asia 2.082
EU - Europa 1.989
AF - Africa 37
OC - Oceania 12
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 24.361
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.205
CN - Cina 1.081
SG - Singapore 780
FI - Finlandia 447
IT - Italia 280
DE - Germania 279
SE - Svezia 271
FR - Francia 228
UA - Ucraina 192
GB - Regno Unito 167
VN - Vietnam 149
IE - Irlanda 38
IN - India 35
NL - Olanda 28
CA - Canada 27
RU - Federazione Russa 22
HK - Hong Kong 13
AU - Australia 8
GH - Ghana 7
TR - Turchia 7
JP - Giappone 6
NG - Nigeria 6
DK - Danimarca 5
BR - Brasile 4
ES - Italia 4
ET - Etiopia 4
GR - Grecia 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
TZ - Tanzania 4
UG - Uganda 4
BE - Belgio 3
CZ - Repubblica Ceca 3
EU - Europa 3
ID - Indonesia 3
PL - Polonia 3
CL - Cile 2
DJ - Gibuti 2
KR - Corea 2
LT - Lituania 2
NO - Norvegia 2
PT - Portogallo 2
SC - Seychelles 2
ZM - Zambia 2
ZW - Zimbabwe 2
AM - Armenia 1
AT - Austria 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
MT - Malta 1
MW - Malawi 1
MY - Malesia 1
RO - Romania 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 24.361
Salva come PNG Salva come JPEG
Città #
Fairfield 3.138
Woodbridge 2.554
Ann Arbor 1.827
Houston 1.810
Chandler 1.451
Ashburn 1.211
Wilmington 1.109
Seattle 1.085
Cambridge 1.029
Jacksonville 899
Singapore 625
Princeton 467
Santa Clara 464
Boardman 433
San Diego 350
Medford 217
Nanjing 202
Des Moines 199
Beijing 192
Helsinki 153
Roxbury 148
Dong Ket 147
Padova 126
Guangzhou 92
Shenyang 71
Hebei 57
Jiaxing 55
Nanchang 50
Norwalk 48
London 41
Dublin 38
Changsha 34
New York 31
Falls Church 30
Tianjin 28
Jinan 27
Shanghai 25
Ogden 24
Pune 18
Kharkiv 16
Zhengzhou 15
Borås 14
Indiana 14
Kilburn 13
Prescot 13
Dallas 12
Hong Kong 12
Hounslow 12
Haikou 11
Milan 11
Redwood City 11
Phoenix 10
Rockville 9
Lappeenranta 8
Amsterdam 7
Hangzhou 7
Los Angeles 7
Tappahannock 7
Toronto 7
Hefei 6
Orange 6
Rome 6
San Francisco 6
Accra 5
Chiswick 5
Lanzhou 5
Legnaro 5
Montréal 5
Nanterre 5
New Bedfont 5
Ningbo 5
Rozzano 5
Acton 4
Chicago 4
Copenhagen 4
Dar es Salaam 4
Dearborn 4
East Lansing 4
Fuzhou 4
Genoa 4
Hanover 4
Islington 4
Kunming 4
Leeds 4
Monselice 4
Munich 4
Redmond 4
Washington 4
Adelaide 3
Athens 3
Biella 3
Brno 3
Brussels 3
Caprino Veronese 3
Falkenstein 3
Florence 3
Groningen 3
Ibadan 3
Leiden 3
Mersin 3
Totale 20.890
Salva come PNG Salva come JPEG
Nome #
Telomere shortening in mucosa surrounding the tumor: Biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma. 184
Analysis of Epstein-Barr virus (EBV) type and variant in spontaneous lymphoblastoid cells and Hu-SCID mouse tumours 179
Genetic, epigenetic and immunologic profiling of MMR-deficient relapsed glioblastoma 173
Role of miR-15a/miR-16-1 and TP53 axis in regulating telomerase expression in chronic lymphocytic leukemia 155
Premature aging and immune senescence in HIV-infected children 147
The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients 147
Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: Impact of mTOR inhibitors 146
Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. 140
Human Immunodeficiency Virus (HIV)-Antibody Repertoire Estimates Reservoir Size and Time of Antiretroviral Therapy Initiation in Virally Suppressed Perinatally HIV-Infected Children 137
Immune senescence and immune activation in elderly colorectal cancer patients 136
Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus 134
DOMINANCE OF A SINGLE EPSTEIN-BARR-VIRUS STRAIN IN SCID-MOUSE TUMORS INDUCED BY INJECTION OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM HEALTHY-HUMAN DONORS 133
Post-transplant lymphoproliferative disorders: From epidemiology to pathogenesis-driven treatment 129
hTERT Inhibition Triggers Epstein-Barr Virus Lytic Cycle and Apoptosis in Immortalized and Transformed B Cells: A Basis for New Therapies. 127
Natural history of M-MSV tumors in mice carrying endogenized Moloney leukemia virus. 124
Reliable and versatile immortal muscle cell models from healthy and myotonic dystrophy type 1 primary human myoblasts 122
Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications 121
Early and Highly Suppressive ART are Main Factors Associated with Low Viral Reservoir in European Perinatally HIV Infected Children 120
Age-related standards for total lymphocyte, CD4(+) and CD8(+) T cell counts in children born in Europe 117
hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: Implications for EBV-driven lymphomagenesis 117
Spontaneous lymphomas in SJL/J-(v+) mice: ecotropic and dualtropic virus expression in normal and lymphomatous tissues. 117
Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution. 117
Accelerated aging in perinatally HIV-infected children: clinical manifestations and pathogenetic mechanisms 117
Differences in telomere length between sporadic and familial cutaneous melanoma 116
Immunological findings in the CSF of HIV-1-infected patients. 114
Predictive and prognostic significance of telomerase levels/telomere length in tissues and peripheral blood in head and neck squamous cell carcinoma 113
Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. 112
Acquired Immunodeficiency Syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome 111
Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes 111
Immunologic abnormalities in angioimmunoblastic lymphadenopathy. 111
Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection. 111
Vulvar carcinoma in a 12-year-old girl with vertically acquired human immunodeficiency virus infection 109
Characterization of dualtropic type C retroviruses isolated from spontaneous non-T lymphomas of SJL/J(V+) mice. 107
Cordycepin reduces the sensitivity of BALB/Mo mouse lymphocytes to the induction of sister chromatid exchanges. 107
HTLV-III and HTLV-I infection in populations at risk in the Veneto region of Italy. 107
Predictive factors of the response of rectal cancer to neoadjuvant radiochemotherapy. 107
PRIMARY LYMPHOMA OF THE CENTRAL-NERVOUS-SYSTEM IN 2 CHILDREN WITH ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME 106
A new epitope presenting system displays a HIV-1 V3 loop sequence and induces neutralizing antibodies. 106
Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers 105
Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission 105
Italian consensus statement on paediatric HIV infection. 105
Role of infectious virus expression and immune response in retrovirus-induced oncogenesis. 105
Telomere and Telomerase in Carcinogenesis: Their Role as Prognostic Biomarkers 105
Lack of M-MuSV tumour regression associated with T lymphocyte tolerance. 105
HIV-infected pregnant women and vertical transmission in Europe since 1986 104
Cerebrospinal fluid lymphocytes from HIV-infected patients synthesize HIV-specific antibody in vitro. 104
Modifications of HIV-1 DNA and provirus-infected cells during 24 months of intermittent highly active antiretroviral therapy 103
HIV-1 with Multiple CCR5/CXCR4 Chimeric Receptor Use Is Predictive of Immunological Failure in Infected Children 103
Risk factors for mother-to-child transmission of HIV-1. 103
CCR5 N-terminus peptides enhance X4 HIV-1 infection by CXCR4 up-regulation 102
The immunological and virological consequences of planned treatment interruptions in children with HIV infection. 102
Immune senescence and cancer in elderly patients: results from an exploratory study. 102
Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells 102
Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions 101
Design, synthesis and CD4 binding studies of a fluorescent analogue of a peptide that enhances HIV-1 infectivity 100
Tolerance to viral antigens in Mov-13 mice carrying endogenized Moloney-murine leukemia virus. 100
Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children 100
Central nervous system involvement in HIV infection. 100
Pattern of antibody response against the V3 loop in children with vertically acquired immunodeficiency virus type 1 (HIV-1) infection. 99
Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system. 99
TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma 99
Epstein-Barr virus and telomerase: from cell immortalization to therapy. 98
Genetic variants of the TERT gene, telomere length, and circulating tert as prognostic markers in rectal cancer patients 98
Latent Membrane Protein 1 of Epstein-Barr Virus Activates the hTERT Promoter and Enhances Telomerase Activity in B Lymphocytes 97
Response to planned treatment interruptions in HIV infection varies across childhood 97
Human immunodeficiency virus type 1 modulates telomerase activity in peripheral blood lymphocytes 97
The prevalence of HTLV-III and HTLV-I antibodies in serum of hemophiliacs. 97
HTLV-I/II seroprevalence in The Gambia: a study of mother-child pairs. 97
A randomized double-blinded trial of the addition of lamivudine or matching placebo to current nucleoside analogue reserve transcriptase inhibitor therapy in HIV-onfected children. The PENTA 4 trial. 96
Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I. 96
Regulatory T cells and chronic immune activation in human immunodeficiency virus 1 (HIV-1)-infected children 96
A search for human herpesvirus 8 (HHV-8) in HIV-1 infected mothers and their infants does not suggest vertical transmission of HHV-8 96
Serological and molecular evidence of infection by human T-cell lymphotropic virus type II in Italian drug addicts by use of synthetic peptides and polymerase chain reaction. 96
Combination antiretroviral therapy and duration of pregnancy 95
Infection of Epstein-Barr virus-transformed lymphoblastoid B cells by the human immunodeficiency virus: evidence for a persistent and productive infection leading to B cell phenotypic changes. 94
Sister chromatid exchanges induced in vivo and in vitro by chemical carcinogens in mouse lymphocytes carrying endogenized Moloney leukemia virus. 94
Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies. 94
Polymorphims of innate immunity genes influence disease progression in HIV-1 infected children 94
Increasing likelihood of further live births in HIV-infected women in recent years 94
HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil. 94
STRUCTURAL STUDIES ON SYNTHETIC PEPTIDES FROM THE PRINCIPAL NEUTRALIZING DOMAIN OF HIV-1 GP120 THAT BIND TO CD4 AND ENHANCE HIV-1 INFECTION 93
Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness 93
Polymorphisms of innate immunity genes influence disease progression in HIV-1-infected children. 93
Free Light-chains of Immunoglobulins In the Cerebrospinal-fluid of Human-immunodeficiency-virus Type-1-infected Patients 93
Different distribution of HIV type 1 genetic variants in European patients with distinct risk practices 92
Levels and patterns of HIV RNA viral load in untreated pregnant women 92
Human immunodeficiency virus type 1 Tat protein modulates cell cycle and apoptosis in Epstein-Barr virus-immortalized B cells 92
Intrathecal synthesis of anti-HIV oligoclonal IgG in HIV-seropositive patients having no signs of HIV-induced neurologic diseases. 92
Age dependence and genetics of expression of ecotropic murine leukemia virus in SJL/J mice. 92
Early antiretroviral therapy in children perinatally infected with HIV: A unique opportunity to implement immunotherapeutic approaches to prolong viral remission 92
Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial 91
Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers 91
Analysis of the CC chemokine receptor 5 m303 mutation in infants born to HIV-1-seropositive mothers. 91
HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. 91
Relationship between Moloney MSV tumor resistance and endogenous virogene expression in AKR mouse strain and its hybrids. 91
Immunological markers in HIV-infected pregnant women. 90
A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: The PERA (PENTA 8) trial 90
SYNTHETIC PEPTIDES FROM THE PRINCIPAL NEUTRALIZING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ENHANCE HIV-1 INFECTION THROUGH A CD4-DEPENDENT MECHANISM 90
Multicenter comparative study of Epstein-Barr virus DNA quantification for virological monitoring in transplanted patients 89
Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease. 89
Totale 10.787
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.800
article - articoli 85.570
book - libri 1.352
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 602
selected - selezionate 0
volume - volumi 484
Totale 179.808
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.744 0 0 0 0 0 360 435 538 513 449 233 216
2020/20212.898 107 332 113 283 87 167 136 339 410 302 320 302
2021/20224.288 119 546 544 332 136 298 230 509 165 74 467 868
2022/20232.885 682 314 40 378 401 441 5 163 316 13 94 38
2023/20241.161 41 174 97 91 96 79 80 45 61 34 193 170
2024/20252.137 21 464 280 287 938 147 0 0 0 0 0 0
Totale 24.511